December 05-07, 2024 Panorama Hotel Prague Milevská 1695/7, 140 63 Praha 4-Nusle, Czechia, Prague, Czech Republic
Abstract Submission Deadline: October 15 , 2024
Standard Registration Deadline: 21-11-2024
Dear Colleagues,
It is my pleasure to cordially invite you all to join the “World Summit on Vaccines Research and Development (WSVRD-2024)” which will be held in Prague, Czech Republic during December 5-7, 2024.
WSVRD-2024 is the ideal opportunity for research scientists, academics, leading experts and students working on Vaccines Research and Development to discuss their cutting-edge innovations, ideas and recent achievements. The meeting will cover both Vaccines Research and Development, COVID-19 vaccines, viral vector vaccines, genetic vaccines, HIV & AIDS vaccines, cancer vaccines, vaccines safety, Vaccine process development & production and other topics.
WSVRD-2024 will be a three-day event that gathers together key players of the Vaccines Research and Development and related sectors. This event aims to attract global participant’s intent on sharing, exchanging and exploring new avenues of Vaccines Research and Development related scientific and commercial developments.
The wide-ranging scientific program will consist of plenary lectures, keynote lectures, invited lectures, parallel sessions, as well as poster sessions for young scientists covering all topics in Vaccines Research and Development. This conference provides a wonderful opportunity for you to enhance your knowledge about the newest interdisciplinary approaches in Vaccines Research and Development. Moreover, the conference offers a valuable platform to create new contacts in the field of Vaccines Research and Development, by providing valuable networking time for you to meet great personnel in the field.
We look forward to seeing you at WSVRD-2024 in Prague, Czech Republic.
Sincerely,,
Prof. Shoenfeld Yehuda
Conference chair | WSVRD-2024.
Reichman University, Israel.
Vancouver Infectious Diseases Centre
Canada
Queen's University Belfast
UK
University of Coimbra
Portugal
Sydney Children's Hospital
Australia
Mayo Clinic and Foundation
USA
Reichman University
Herzelia, Israel
CEO Afrigen Biologics& Vaccines
South Africa
World Health Organization Regional Office for South-East Asia
India
President and CEO of Biological Mimetics, Inc.,
USA
CEO of PharSafer
United Kingdom
Head National Vaccines & Immunization Program, Ministry of Health
Kenya
McGill University
Canada
Belgrade University, Serbia
French society of Immunology
France
King's College London
UK
University of Alabama at Birmingham
USA
Ministry of Health in Saudi Arabia
Saudi Arabia
Hon'ble Vice Chancellor, Aryabhatta Knowledge University
Bihar India
University of Pisa
Italy
University of Pisa
Italy
Jiangsu Provincial Center for Disease Control and Prevention
china
University of Pisa
Italy
University of Molise
Italy
Ceva Santé Animale
India
University Kore of Enna
Italy
University of Nigeria, UNN Nsukka
Nigeria
Rwanda Biomedical Centre
Rwanda
SRM Institute of Science and Technology
India
Reichman University
Herzelia, Israel
CEO Afrigen Biologics& Vaccines
South Africa
World Health Organization Regional Office for South-East Asia
India
President and CEO of Biological Mimetics, Inc.,
USA
CEO of PharSafer
United Kingdom
Head National Vaccines & Immunization Program, Ministry of Health
Kenya
McGill University
Canada
Belgrade University, Serbia
French society of Immunology
France
King's College London
UK
University of Alabama at Birmingham
USA
Ministry of Health in Saudi Arabia
Saudi Arabia
Hon'ble Vice Chancellor, Aryabhatta Knowledge University
Bihar India
University of Pisa
Italy
University of Pisa
Italy
Jiangsu Provincial Center for Disease Control and Prevention
china
University of Pisa
Italy
University of Molise
Italy
Ceva Santé Animale
India
University Kore of Enna
Italy
University of Nigeria, UNN Nsukka
Nigeria
Rwanda Biomedical Centre
Rwanda
SRM Institute of Science and Technology
India
attenuated vaccines
Inactivated vaccines
Toxoid vaccines
Subunit, recombinant, polysaccharide, and conjugate vaccines
Genetic vaccine
Viral vector vaccines
COVID-19 vaccines
Corona Virus and Vaccines
Hepatitis Immunology & Vaccine Biology
Malaria vaccines
Diabetes Vaccines
veterinary vaccines
HIV&AIDS Vaccines
Cancer Vaccines
Therapeutic vaccination for Auto Immune Diseases
DNA Vaccines
Polio Vaccines
Vaccines for Vector-borne Diseases
Cholera vaccine
Tuberculosis vaccine
Typhoid vaccine
Smallpox vaccine
Influenza Vaccine
Vaccines & Immunizations
SARS vaccine.
Bacterial and Viral
Vaccine safety
Vaccine process development & production
cancer immunology and anti-tumor immunity
Rabies Vaccine
